Log in or Sign up for Free to view tailored content for your specialty!
Neurorehabilitation News
Phase 3 clinical trial commences for oral myasthenia gravis treatment
The first patient has been dosed in a phase 3 clinical trial of oral cladribine for the treatment of generalized myasthenia gravis, according to the manufacturer.
Treatment-limiting decisions made in nearly 50% of severe traumatic brain injury cases
Treatment-limiting decisions were made for almost half of patients with severe traumatic brain injuries, with higher rates in those older in age, according to data.
Log in or Sign up for Free to view tailored content for your specialty!
FDA grants fast-track designation to injectable positron emission tomography diagnostic
The FDA has granted fast-track designation to an investigational tau positron emission tomography diagnostic that can be used for a range of neurodegenerative conditions, according to the manufacturer.
Q&A: Removing barriers to access key to expansion of DBS surgery for Parkinson’s
Deep brain stimulation (DBS) therapy has been a safe and effective treatment option for Parkinson’s disease for more than 30 years, but another surgical option for the therapy has emerged.
Early OSA intervention may lead to better outcomes in infants with Down syndrome
For infants with Down syndrome, early intervention to address obstructive sleep apnea may lead to better cognitive and behavioral outcomes at 36 months, according to new research from The Lancet.
FDA clears cyber device, AI system to address glioblastoma
An Alabama-based company announced that the FDA has granted 510(k) clearance to its cyber device and AI system, which are designed to improve efficiency and accuracy of glioblastoma care.
Longeviti Neuro Solutions secures US patent for neurosurgical cranial implant
A Maryland-based neurotechnology company has secured a U.S. patent for its novel prosthetic translucent, cranial implant intended for use during neurosurgical procedures.
FDA grants 510(k) clearance to hemostatic gel for moderate to severe bleeding
The FDA has granted 510(k) clearance to a plant-based, hemostatic gel to treat moderate to severe bleeding, according to the manufacturer.
Over 150 minutes of weekly aerobic exercise after concussion improves sleep
Over 150 minutes of aerobic exercise a week following a concussion improved sleep quality in adolescents, study results published in The Journal of Head Trauma Rehabilitation showed.
FDA grants rare pediatric disease designation for Duchenne muscular dystrophy treatment
The FDA has granted rare pediatric disease designation to an investigational oligonucleotide for the treatment of boys with Duchenne muscular dystrophy who are amenable to exon 53 skipping, according to the manufacturer.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read